• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Recent Advances in the Application of 3-Isopropoxy-benzenesulfonyl Chloride (CAS: 69129-61-9) in Chemical Biology and Pharmaceutical Research

3-Isopropoxy-benzenesulfonyl chloride (CAS: 69129-61-9) is a key intermediate in organic synthesis, particularly in the development of sulfonamide-based compounds. Recent studies have highlighted its utility in medicinal chemistry, where it serves as a versatile building block for the synthesis of biologically active molecules. This research briefing provides an overview of the latest advancements involving this compound, focusing on its applications in drug discovery and chemical biology.

One of the most notable applications of 3-Isopropoxy-benzenesulfonyl chloride is in the synthesis of sulfonamide derivatives, which are widely used in pharmaceuticals due to their antibacterial, antiviral, and anti-inflammatory properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its role in the development of novel inhibitors targeting carbonic anhydrase isoforms, which are implicated in various diseases, including glaucoma and cancer. The study reported that derivatives synthesized using this compound exhibited high selectivity and potency, making them promising candidates for further preclinical evaluation.

In addition to its medicinal applications, 3-Isopropoxy-benzenesulfonyl chloride has been employed in chemical biology for the modification of biomolecules. Recent research has explored its use in the site-specific sulfonylation of proteins and peptides, enabling the study of protein-protein interactions and post-translational modifications. A 2024 paper in Angewandte Chemie detailed a novel method for the selective sulfonylation of lysine residues, leveraging the reactivity of this compound to achieve high yields and minimal side reactions. This technique opens new avenues for probing biological systems and designing therapeutic agents.

The compound's utility extends to materials science, where it has been used to synthesize sulfonated polymers with applications in drug delivery and tissue engineering. A recent study in ACS Applied Materials & Interfaces highlighted the development of a sulfonated hydrogel using 3-Isopropoxy-benzenesulfonyl chloride as a cross-linking agent. The resulting material exhibited excellent biocompatibility and controlled release properties, making it suitable for targeted drug delivery systems.

Despite its widespread use, challenges remain in the handling and storage of 3-Isopropoxy-benzenesulfonyl chloride due to its sensitivity to moisture and potential for decomposition. Recent advancements in synthetic methodologies have addressed these issues, with researchers developing more stable derivatives and improved purification techniques. A 2023 review in Organic Process Research & Development summarized these innovations, emphasizing the importance of optimizing reaction conditions to enhance yield and purity.

In conclusion, 3-Isopropoxy-benzenesulfonyl chloride (CAS: 69129-61-9) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility in synthesizing sulfonamide derivatives, modifying biomolecules, and developing advanced materials underscores its significance in the field. Ongoing research aims to further expand its applications and overcome existing limitations, paving the way for new discoveries and therapeutic innovations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)